A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

NCT04837222 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda